Camlin Fine Sciences to hold 33rd AGM on Aug 11, 2026, to adopt FY26 financials
Camlin Fine Sciences will hold its 33rd AGM on August 11, 2026, via VC/OAVM. The meeting will adopt audited financial statements for FY 2025-26 and re-appoint directors Mr. Harsha Raghavan and Mr. Jens Van Nieuwenborgh. Remote e-voting is open from August 8-10, 2026.
This is a standard corporate event (AGM) and a notice of the meeting, which is a routine procedure. It does not involve any new business developments, financial results, or strategic decisions that would significantly impact the company's stock or operations.
The announcement is a routine procedural notice regarding the Annual General Meeting and does not contain any new financial performance data or strategic changes that would indicate a positive or negative sentiment.
Camlin Fine Sciences Limited has announced its 33rd Annual General Meeting (AGM) for the financial year 2025-26. The AGM is scheduled to be held on Tuesday, August 11, 2026, at 10:00 a.m. IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The primary agenda for the meeting includes the consideration and adoption of the audited financial statements for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors. This will cover both standalone and consolidated financial statements.
Additionally, the AGM will address the re-appointment of Mr. Harsha Raghavan and Mr. Jens Van Nieuwenborgh as Non-Executive Non-Independent Directors, both of whom are retiring by rotation. The meeting will also seek ratification of the remuneration of the Cost Auditor for the financial year ending March 31, 2027.
The notice of the AGM, along with the Annual Report for FY 2025-26, is available on the company's website. The company has provided detailed instructions for members regarding remote e-voting, which will commence on Saturday, August 8, 2026, at 9:00 AM IST and conclude on Monday, August 10, 2026, at 5:00 PM IST. The cut-off date for determining voting rights is Wednesday, August 5, 2026.
What to do with a filing like this
Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.